Medical Condition News

RSS

Microsulis reports additional IEC electrical safety clearances for Accu2i pMTA system

Microsulis reports that the groundbreaking Accu2i pMTA system for destroying unwanted tissue and used in the treatment of liver and other cancers now carries an impressive range of electrical safety standards. The Accu2i is CE-marked and carries FDA 510(k) clearance and so is cleared for electrical safety and performance with the internationally recognised standard IEC 60601-1 for electrical safety.

12 Nov 2010

Hartford Hospital research team receives $238,000 grant from InHealth to study prostate cancer

The Institute for Health Technology Studies (InHealth) has awarded a grant totaling more than $238,000 to a research team at the Helen & Harry Gray Cancer Center at Hartford Hospital in Connecticut to study how various prostate cancer treatments affect a patient's "social capital" the ability to continue working productively in a paying job.

12 Nov 2010

Scientists create functional neurons to study ASD development

Using induced pluripotent stem cells from patients with Rett syndrome, scientists at the University of California, San Diego School of Medicine have created functional neurons that provide the first human cellular model for studying the development of autism spectrum disorder (ASD) and could be used as a tool for drug screening, diagnosis and personalized treatment.

12 Nov 2010

Chili pepper-shaped wrist bands raise $5.6 million for St. Jude Children's Research Hospital

The must-have tween accessory of 2010 the collectible rubber bracelet helped Chili's Grill & Bar raise $5.6 million for St. Jude Children's Research Hospital this year. $1 from each $3, five-pack of chili pepper-shaped wrist bands sold benefited Chili's annual fundraiser to St. Jude, the nation's top ranked children's cancer hospital. The wrist bands proved so popular that they sold out in restaurants nationwide in less than 30 days.

12 Nov 2010

Alcohol damages liver, weakens immune system, slows healing, impairs bone formation, and much more

Alcohol does much more harm to the body than just damaging the liver. Drinking also can weaken the immune system, slow healing, impair bone formation, increase the risk of HIV transmission and hinder recovery from burns, trauma, bleeding and surgery.

12 Nov 2010

Seven stages of Alzheimer's disease

Now, during Alzheimer's Awareness month, is an important time to recognize Alzheimer's and its symptoms. Alzheimer's is the most common form of dementia that has a higher risk factor with increasing age. It is a progressive disease that worsens with time. Besides the most common early symptom of Alzheimer's, which is difficulty remembering new information, there are seven stages of Alzheimer's, according to the Alzheimer's Association. It is important to track the different stages to have an understanding and be an efficient caregiver to a loved one.

12 Nov 2010

Carter Center, Merck take steps to prevent river blindness in Latin America

Public health officials at the 20th Inter-American Conference on Onchocerciasis in Antigua, Guatemala, confirmed that more than one-third of all Latin Americans who ran the risk of contracting river blindness (onchocerciasis), a leading cause of preventable blindness, are no longer at risk.

12 Nov 2010

Neuroscience of magic

The unorthodox research collaboration between two Barrow Neurological Institute scientists and some of the world's greatest magicians is detailed in a new book called Sleights of Mind.

12 Nov 2010

Neural pathways in amygdala regulates fear response

Fear arises in the almond-shaped brain structure known as the amygdala. It is the amygdala which processes the strange noise, shadowy figure or scary face and not only triggers palpitations or nausea but can also cause us to flee or freeze. That much has long been known about the function of this part of the brain. What remains largely unclear, however, is precisely how fear develops, and which of the countless neurons in the amygdaloid region are involved in this process.

12 Nov 2010

GPR124 protein controls growth of blood vessels into brains

One protein single-handedly controls the growth of blood vessels into the developing brains of mice embryos, according to researchers at the Stanford University School of Medicine. Understanding how the protein, a cellular receptor, functions could help clinicians battle brain tumors and stroke by choking off or supplementing vital blood-vessel development, and may enhance the delivery of drugs across the blood-brain barrier.

12 Nov 2010

Research on fruit flies reveal novel human pain gene

While it has become clear in recent years that susceptibility to pain has a strong inherited component, very little is known about actual "pain genes" and how they work. In the November 12th issue of Cell, researchers at Children's Hospital Boston and their collaborators report on a novel human pain gene. People with minor variations in this gene showed clear differences in susceptibility to acute heat pain and chronic back pain.

12 Nov 2010

Research unveils epigenetic function of MECP2 gene tht cause neuropsychiatric disorders

The laboratory of Huda Zoghbi, where the discovery that mutations in the gene MECP2 cause the severe childhood neurological disorder Rett Syndrome was made, has taken yet another step toward unraveling the complex epigenetic functions of this gene, implicated also in cases of autism, bipolar disease and childhood onset schizophrenia. The November 11 issue of Nature reports that removing MECP2 from a small group of neurons that typically make the inhibitory neurotransmitter, GABA, recapitulates many symptoms of Rett as well as numerous neuropsychiatric disorders.

12 Nov 2010

ASN Annual Meeting to highlight six late-breaking clinical trials on nephrology

Six late-breaking clinical trials have been accepted for presentation next week during the American Society of Nephrology's 43rd Annual Meeting and Scientific Exposition in Denver, CO. These trials were selected based upon their potential impact to the field of nephrology.

12 Nov 2010

Oligomerix receives SBIR Phase II grant to develop drugs for Alzheimer’s disease

Oligomerix, Inc. today announced the receipt of a two-year Small Business Innovation Research (SBIR) Phase II grant for $1.6M from the National Institute on Aging, National Institutes of Health (NIH), for a program to discover small molecules and antibodies targeting tau protein oligomers in the development of disease modifying therapeutics for Alzheimer's disease.

12 Nov 2010

Elevated levels of MCP-1 found in urine of patients with acute kidney injury

The presence of certain markers in the urine might be a red flag for acute kidney injury (AKI), according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results suggest that a simple urine test could help prevent cases of kidney failure.

12 Nov 2010

Reata to present bardoxolone methyl Phase 2b clinical trial data for CKD, type 2 diabetes at ASN Conference

Reata Pharmaceuticals today announced that the company will present data on the primary endpoint from a pivotal Phase 2b clinical trial of bardoxolone methyl in patients with chronic kidney disease (CKD) and type 2 diabetes. The data will be presented in a late-breaking oral presentation at the American Society of Nephrology (ASN) Renal Week Conference to be held November 16-21, 2010, in Denver, Colorado.

12 Nov 2010

ESMO-symposium to highlight recent advancement in cancer biology

This ESMO-symposium will allow bed-side oriented oncologists to grasp key and timely-issues related to cancer biology. All presentations will have a clear focus towards potential clinical implications thus helping clinicians fully comprehend the major consequences that new developments in cancer biology may have in daily care.

12 Nov 2010

Diabetic drug may retard growth of fluid-filled cysts in PKD: Research

Researchers report that a drug commonly used to treat diabetes may also retard the growth of fluid-filled cysts of the most common genetic disorder, polycystic kidney disease.

12 Nov 2010

New catheter device for abdominal aortic aneurysm

William E. Sorfleet had a life-threatening abdominal aortic aneurysm, but at age 82, he was too old for major invasive surgery to repair the bulging blood vessel. So vascular surgeon Dr. Ross Milner of Loyola University Hospital repaired the aneurysm with a catheter device instead of a scalpel. The catheter, inserted through an artery, deployed a device called a stent graft that repaired the aneurysm.

12 Nov 2010

33rd CTRC-AACR Symposium to feature breast cancer research

The 33rd CTRC-AACR San Antonio Breast Cancer Symposium will feature the latest findings in prevention, epidemiological, laboratory, translational and clinical breast cancer research. This year's symposium will highlight new therapies in the pipeline, new approaches with existing agents and emerging biology that will affect the quest for personalized medicine.

12 Nov 2010

Medical Condition News

Microsulis reports additional IEC electrical safety clearances for Accu2i pMTA system

Hartford Hospital research team receives $238,000 grant from InHealth to study prostate cancer

Scientists create functional neurons to study ASD development

Chili pepper-shaped wrist bands raise $5.6 million for St. Jude Children's Research Hospital

Alcohol damages liver, weakens immune system, slows healing, impairs bone formation, and much more

Seven stages of Alzheimer's disease

Carter Center, Merck take steps to prevent river blindness in Latin America

Neuroscience of magic

Neural pathways in amygdala regulates fear response

GPR124 protein controls growth of blood vessels into brains

Research on fruit flies reveal novel human pain gene

Research unveils epigenetic function of MECP2 gene tht cause neuropsychiatric disorders

ASN Annual Meeting to highlight six late-breaking clinical trials on nephrology

Oligomerix receives SBIR Phase II grant to develop drugs for Alzheimer’s disease

Elevated levels of MCP-1 found in urine of patients with acute kidney injury

Reata to present bardoxolone methyl Phase 2b clinical trial data for CKD, type 2 diabetes at ASN Conference

ESMO-symposium to highlight recent advancement in cancer biology

Diabetic drug may retard growth of fluid-filled cysts in PKD: Research

New catheter device for abdominal aortic aneurysm

33rd CTRC-AACR Symposium to feature breast cancer research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News